Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19). Accessed September 30, 2020. Available at: https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf
Ganatra S, Hammond SP, Nohria A. The novel coronavirus disease (COVID-19) threat for patients with cardiovascular disease and cancer. JACC CardioOncol 2020;2:350–355.
Ganatra S, Dani SS, Shah S, et al. . Management of cardiovascular disease during coronavirus disease (COVID-19) pandemic. Trends Cardiovasc Med 2020;30:315–325.
Kuderer NM, Choueiri TK, Shah DP, et al. . Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study. Lancet 2020;395:1907–1918.
Liang W, Guan W, Chen R, et al. . Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol 2020;21:335–337.
Guan WJ, Ni ZY, Hu Y, et al. . Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020;382:1708–1720.
Zhou F, Yu T, Du R, et al. . Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020;395:1054–1062.
Addison D, Campbell CM, Guha A, et al. . Cardio-oncology in era of the COVID-19 pandemic and beyond [published online July 27, 2020]. J Am Heart Assoc, doi: 10.1161/JAHA.120.017787
Yu J, Ouyang W, Chua MLK, et al. . SARS-CoV-2 transmission in patients with cancer at a tertiary care hospital in Wuhan, China. JAMA Oncol 2020;6:1108–1110.
Meng Y, Lu W, Guo E, et al. . Cancer history is an independent risk factor for mortality in hospitalized COVID-19 patients: a propensity score-matched analysis. J Hematol Oncol 2020;13:75.
Dai M, Liu D, Liu M, et al. . Patients with cancer appear more vulnerable to SARS-CoV-2: a multicenter study during the COVID-19 outbreak. Cancer Discov 2020;10:783–791.
Mehta V, Goel S, Kabarriti R, et al. . Case fatality rate of cancer patients with COVID-19 in a New York hospital system. Cancer Discov 2020;10:935–941.
Lee LYW, Cazier JB, Angelis V, et al. . COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study. Lancet 2020;395:1919–1926.
Guo T, Fan Y, Chen M, et al. . Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol 2020;5:811–818.
Inciardi RM, Adamo M, Lupi L, et al. . Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy. Eur Heart J 2020;41:1821–1829.
Mancia G, Rea F, Ludergnani M, et al. . Renin-angiotensin-aldosterone system blockers and the risk of COVID-19. N Engl J Med 2020;382:2431–2440.
DeSantis CE, Lin CC, Mariotto AB, et al. . Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin 2014;64:252–271.
Ganatra S, Hayek SS. Cardio-oncology for GenNext: a missing piece of the training puzzle. J Am Coll Cardiol 2018;71:2977–2981.
Curigliano G, Lenihan D, Fradley M, et al. . Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations. Ann Oncol 2020;31:171–190.